Quality control limits for broth microdilution susceptibility tests of ten antifungal agents

被引：188

作者：

Barry, AL

Pfaller, MA

Brown, SD

Espinel-Ingroff, A

Ghannoum, MA

Knapp, C

Rennie, RP

Rex, JH

Rinaldi, MG

机构：

[1] Inst Clin Microbiol, Wilsonville, OR 97070 USA

[2] Univ Iowa, Coll Med, Iowa City, IA USA

[3] Virginia Commonwealth Univ, Coll Med, Richmond, VA USA

[4] Univ Ctr Reference Lab Med Mycol, Cleveland, OH USA

[5] Trek Diagnost Syst Inc, Westlake, OH USA

[6] Natl Ctr Mycol, Edmonton, AB, Canada

[7] Univ Texas, Hlth Sci Ctr, Houston, TX USA

[8] Univ Texas, Hlth Sci Ctr, San Antonio, TX USA

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2000年 / 38卷 / 09期

关键词：

D O I：

10.1128/JCM.38.9.3457-3459.2000

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

Broth microdilution susceptibility tests of Candida species have now been standardized by the National Committee for Clinical Laboratory Standards (NCCLS), An eight-laboratory collaborative study was carried out in order to document reproducibility of tests of Candida parapsilosis ATCC 22019 and Candida krusei ATCC 6258 by the NCCLS method. Replicate broth microdilution tests were used to define control limits for 24- and 48-h MICs of amphotericin B, flucytosine, fluconazole, voriconazole, ketoconazole, itraconazole, caspofungin (Mg 0991), ravuconazole (BMS 207147), posaconazole (SCH 56592), and LY 303366.

引用

页码：3457 / 3459

页数：3

共 10 条

[1] STATISTICAL CRITERIA FOR SELECTING QUALITY-CONTROL LIMITS FOR BROTH MICRODILUTION SUSCEPTIBILITY TESTS WITH 39 DIFFERENT ANTIMICROBIAL AGENTS
BARRY, AL
FUCHS, PC
JONES, RN
[J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1989, 12 (05) : 413 - 420
[2] COLLABORATIVE COMPARISON OF BROTH MACRODILUTION AND MICRODILUTION ANTIFUNGAL SUSCEPTIBILITY TESTS
ESPINELINGROFF, A
KISH, CW
KERKERING, TM
FROMTLING, RA
BARTIZAL, K
GALGIANI, JN
VILLAREAL, K
PFALLER, MA
GERARDEN, T
RINALDI, MG
FOTHERGILL, A
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (12) : 3138 - 3145
[3] *NAT COMM CLIN LAB, 1998, M23T3 NAT COMM CLIN
[4] National Committee for Clinical Laboratory Standards, 1997, M27A NAT COMM CLIN L
[5] SELECTION OF CANDIDATE QUALITY-CONTROL ISOLATES AND TENTATIVE QUALITY-CONTROL RANGES FOR IN-VITRO SUSCEPTIBILITY TESTING OF YEAST ISOLATES BY NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS PROPOSED STANDARD METHODS
PFALLER, MA
BALE, M
BUSCHELMAN, B
LANCASTER, M
ESPINELINGROFF, A
REX, JH
RINALDI, MG
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (07) : 1650 - 1653
[6] MULTICENTER EVALUATION OF 4 METHODS OF YEAST INOCULUM PREPARATION
PFALLER, MA
BURMEISTER, L
BARTLETT, MS
RINALDI, MG
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (08) : 1437 - 1441
[7] QUALITY-CONTROL GUIDELINES FOR NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS RECOMMENDED BROTH MACRODILUTION TESTING OF AMPHOTERICIN-B, FLUCONAZOLE, AND FLUCYTOSINE
PFALLER, MA
BALE, M
BUSCHELMAN, B
LANCASTER, M
ESPINELINGROFF, A
REX, JH
RINALDI, MG
COOPER, CR
MCGINNIS, MR
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (05) : 1104 - 1107
[8] A randomized trial of continuous or intermittent therapy with fluconazole for oropharyngeal candidiasis in HIV-infected patients: Clinical outcomes and development of fluconazole resistance
Revankar, SG
Kirkpatrick, WR
McAtee, RK
Fothergill, AW
Redding, SW
Rinaldi, MG
Hilsenbeck, SG
Patterson, TF
[J]. AMERICAN JOURNAL OF MEDICINE, 1998, 105 (01) : 7 - 11
[9] Quality control guidelines for National Committee for clinical laboratory standards-recommended broth macrodilution testing of ketoconazole and itraconazole
Rex, JH
Pfaller, MA
Lancaster, M
Odds, FC
Bolmstrom, A
Rinaldi, MG
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (04) : 816 - 817
[10] Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis
Rex, JH
Nelson, PW
Paetznick, VL
Lozano-Chiu, M
Espinel-Ingroff, A
Anaissie, EJ
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (01) : 129 - 134

← 1 →